5R08 | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY A07, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, (2-aminopyridin-3-yl)methanol | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.7 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R09 | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY B03, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, 2-[(1~{S})-1-azanylpropyl]phenol | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.56 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0A | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY C02, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, 2,4,5-tris(fluoranyl)-3-methoxy-benzoic acid | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.54 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0B | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY C05, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, 2-methoxy-4-[[(4~{S},5~{S})-2,4,5-tris(2-methoxypyridin-4-yl)imidazolidin-1-yl]methyl]pyridine | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.82 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0C | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY C08, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, (3S)-3-hydroxy-2-methyl-2,3-dihydro-1H-isoindol-1-one | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.6 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0D | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY C11, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, N-ethyl-N-(thiophene-2-carbonyl)-beta-alanine | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.27 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0E | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY D02, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, ~{N}-[5-azanyl-2,4-bis(fluoranyl)phenyl]propane-1-sulfonamide | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.59 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0F | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY D06, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, (3-methoxyphenyl)(pyrrolidin-1-yl)methanone | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.97 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0G | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY D07, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, 2-fluoranyl-~{N}-(furan-2-ylmethyl)benzenesulfonamide | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.73 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0H | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY E05, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, 2-(2-methylphenyl)acetamide | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.57 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0I | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY E12, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, 6-azanyl-3-methyl-1,3-benzoxazol-2-one | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.86 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0J | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY F08, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, 4-[(methylamino)methyl]phenol | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.81 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0K | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY G12, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, ~{N}-[(~{E})-thiophen-2-ylmethylideneamino]cyclopropanecarboxamide | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.8 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0L | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY H11, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, N-cyclopentyl-N'-{[(2R)-oxolan-2-yl]methyl}urea | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.7 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0M | | PANDDA ANALYSIS GROUP DEPOSITION -- AAR2/RNASEH IN COMPLEX WITH FRAGMENT F2X-ENTRY H12, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2, ~{N}-(2-thiophen-2-ylethyl)pyridine-4-carboxamide | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.7 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0N | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 01, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.78 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0O | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 02, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.86 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0P | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 03, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.73 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0Q | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 04, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.91 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0R | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 05, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.73 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0S | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 06, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.81 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0T | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 07, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.96 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0U | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 08, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.86 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0V | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 09, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.81 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
5R0W | | PANDDA ANALYSIS GROUP DEPOSITION -- AUTO-REFINED DATA OF AAR2/RNASEH FOR GROUND STATE MODEL 10, DMSO-FREE | | Descriptor: | Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 | | Authors: | Wollenhaupt, J., Metz, A., Barthel, T., Lima, G.M.A., Heine, A., Mueller, U., Klebe, G., Weiss, M.S. | | Deposit date: | 2020-02-12 | | Release date: | 2020-06-03 | | Last modified: | 2020-06-17 | | Method: | X-RAY DIFFRACTION (1.86 Å) | | Cite: | F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28, 2020
|
|
